照護現場血糖測試市場規模、佔有率、成長分析，按類型、按應用、按最終用戶、按地區 - 行業預測，2025-2032 年

2023 年照護現場血糖測試市場規模預計為 34.4 億美元，從 2024 年的 35.8 億美元成長到 2032 年的 49.8 億美元，預測期間（2025-2032 年）預計將以 4.2% 的複合年成長率成長。

在糖尿病盛行率上升以及對便利性即時血糖監測解決方案的需求的推動下，全球照護現場血糖檢測市場正在顯著成長。可攜式測試設備使醫療保健專業人員和患者能夠在照護端快速評估血糖值，從而促進更好的疾病管理並改善患者的治療結果。技術進步和人們對常規血糖監測重要性的認知不斷提高，支持了市場的擴張。但需要注意設備價格、確保檢測精度等問題。特別是，創新機會比比皆是，包括新的生物感測器技術以及與數位健康平台的整合，這最終將簡化護理並改善糖尿病管理，並為世界各地的患者提供幫助，這是一個旨在降低醫療保健成本的市場。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析

照護現場血糖測試市場規模：按類型

• 市場概況
• 穿刺裝置和條帶
• 血糖值儀

照護現場血糖檢測市場規模：依應用分類

• 市場概況
• 1型糖尿病
• 2型糖尿病

照護現場

• 市場概況
• 醫院和診所
• 家庭護理設置
• 其他

照護現場血糖檢測市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• Abbott Laboratories（USA）
• Roche Holding AG（Switzerland）
• Ascensia Diabetes Care Holdings AG（Switzerland）
• Dexcom, Inc.（USA）
• Medtronic plc（Ireland）
• LifeScan, Inc.（USA）
• Becton, Dickinson and Company（BD）（USA）
• ACON Laboratories, Inc.（USA）
• Nova Biomedical Corporation（USA）
• ARKRAY, Inc.（Japan）
• Trividia Health, Inc.（USA）
• PTS Diagnostics（USA）
• Nipro Corporation（Japan）
• Ypsomed Holding AG（Switzerland）
• Sanofi SA（France）
• EKF Diagnostics Holdings plc（UK）
• Prodigy Diabetes Care, LLC（USA）
• Bayer AG（Germany）
• Danaher Corporation（USA）
• Platinum Equity Advisors, LLC（USA）

結論和建議

Point-of-care Glucose Testing Market size was valued at USD 3.44 Billion in 2023 and is poised to grow from USD 3.58 Billion in 2024 to USD 4.98 Billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).

The global point-of-care glucose testing market is experiencing substantial growth, fueled by the rising prevalence of diabetes and the demand for convenient, immediate glucose monitoring solutions. Portable testing devices enable healthcare professionals and patients to rapidly assess blood sugar levels at the point of care, promoting better disease management and improved patient outcomes. The market's expansion is supported by advancements in technology and heightened awareness of the importance of routine glucose monitoring. However, challenges like device affordability and ensuring test accuracy need attention. Opportunities for innovation abound, particularly with emerging biosensor technologies and integration with digital health platforms, positioning the market to enhance diabetes management and empower patients worldwide, ultimately aiming to streamline care and reduce healthcare costs.

Top-down and bottom-up approaches were used to estimate and validate the size of the Point-Of-Care Glucose Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Point-Of-Care Glucose Testing Market Segmental Analysis

Global Point-Of-Care Glucose Testing Market is segmented by type, application, end user and region. Based on type, the market is segmented into lancing devices and strips and blood-glucose meter. Based on application, the market is segmented into type-1 diabetes and type-2 diabetes. Based on end user, the market is segmented into hospitals and clinics, home care settings and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Point-Of-Care Glucose Testing Market

One of the primary catalysts for growth in the point-of-care glucose testing market is the rising prevalence of diabetes worldwide. As reported by the International Diabetes Federation, the number of adults diagnosed with diabetes is projected to soar to 700 million by 2045. This alarming increase highlights the critical need for consistent glucose monitoring to manage the condition effectively. Consequently, the growing population of diabetes patients significantly boosts the demand for point-of-care testing devices, which offer timely and convenient monitoring solutions. This trend underscores the vital role that these testing systems play in improving patient care and health outcomes in diabetes management.

Restraints in the Point-Of-Care Glucose Testing Market

One significant restraint on the Point-of-Care Glucose Testing market is the high cost associated with testing devices and related consumables. This financial barrier can impede market expansion, especially in developing areas where healthcare resources are scarce, and disposable incomes are lower. The elevated prices of these testing devices may deter extensive adoption, particularly within low-income populations and healthcare institutions operating under budget limitations. As a result, the affordability issue poses a challenge to the accessibility of point-of-care glucose testing, thereby affecting its utilization and potential growth in various regions where economic constraints exist.

Market Trends of the Point-Of-Care Glucose Testing Market

The Point-Of-Care Glucose Testing market is increasingly characterized by the integration of testing devices with digital health platforms and electronic health records. This trend, gaining momentum through 2022 and beyond, facilitates seamless data transfer and real-time monitoring of glucose levels, enhancing patient engagement in diabetes management. By empowering individuals with actionable insights and enabling healthcare professionals to access comprehensive patient data, this integration supports informed decision-making and personalized treatment plans. As technology continues to advance, the demand for interconnected health solutions is expected to grow, driving innovations in the Point-Of-Care Glucose Testing sector and improving patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Point-Of-Care Glucose Testing Market Size by Type & CAGR (2025-2032)

• Market Overview
• Lancing Devices and Strips
• Blood-Glucose Meter

Global Point-Of-Care Glucose Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Type-1 Diabetes
• Type-2 Diabetes

Global Point-Of-Care Glucose Testing Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals and Clinics
• Home Care Settings
• Others

Global Point-Of-Care Glucose Testing Market Size & CAGR (2025-2032)

• North America (Type, Application, End User)
  • US
  • Canada
• Europe (Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeScan, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACON Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nova Biomedical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trividia Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PTS Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics Holdings plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prodigy Diabetes Care, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Platinum Equity Advisors, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations